Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • Hydroxychloroquine Sulfate CAS 747-36-4 Supplier and Production Information

Dec . 28, 2024 18:06 Back to list

Hydroxychloroquine Sulfate CAS 747-36-4 Supplier and Production Information



The Manufacturer of Hydroxychloroquine Sulfate (CAS 747-36-4)


Hydroxychloroquine sulfate, designated by the Chemical Abstracts Service (CAS) number 747-36-4, is a well-known medication primarily used for the treatment of malaria, lupus, and rheumatoid arthritis. This medication has garnered significant attention in recent years, particularly during the COVID-19 pandemic, leading to increased interest in its manufacturing processes, safety profiles, and efficacy.


Overview of Hydroxychloroquine Sulfate


Hydroxychloroquine is an antimalarial drug that belongs to the class of medications known as quinolines. Its mechanism of action involves the inhibition of the growth of parasites in red blood cells and modulating the immune response. For patients with autoimmune conditions, hydroxychloroquine can help to manage symptoms and prevent flares, making it an invaluable option in clinical settings.


Manufacturing Process


The production of hydroxychloroquine sulfate involves several critical steps to ensure product quality, efficacy, and safety. The manufacturing process typically begins with the synthesis of the active pharmaceutical ingredient (API). This includes the careful combination of raw chemical materials under controlled conditions to produce hydroxychloroquine sulfate.


Manufacturers adhere to Good Manufacturing Practices (GMP) as outlined by regulatory authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). This ensures that every step of the production process, from raw materials to finished product, meets stringent quality and safety standards. The facilities involved in the manufacturing process are routinely inspected to ensure compliance with these regulations.


Challenges in Manufacturing


hydroxychloroquine sulfate cas747-36-4 manufacturer

hydroxychloroquine sulfate cas747-36-4 manufacturer

The production of hydroxychloroquine has faced several challenges, particularly during times of higher demand. The COVID-19 pandemic prompted a surge in inquiries and demands for hydroxychloroquine, which led to concerns about potential shortages and the ability of manufacturers to meet increased needs. Safety and integrity of supply chains became paramount, as many manufacturers worked tirelessly to scale production while ensuring compliance with health regulations.


Additionally, variations in raw material sourcing, production timelines, and the need for rapid testing prior to distribution can complicate the manufacturing landscape. Manufacturers must maintain a careful balance between increasing output and ensuring the safety, quality, and efficacy of the medication.


Quality Control


Quality control is a pivotal aspect of hydroxychloroquine sulfate manufacturing. Rigorous testing processes are in place to ascertain the purity, potency, and overall quality of the final product. This includes both physical and chemical analyses performed by qualified laboratory personnel using sophisticated equipment and methodologies.


Moreover, manufacturers often participate in post-marketing surveillance programs to monitor the safety and efficacy of hydroxychloroquine in the market. This ongoing assessment plays a critical role in identifying any potential adverse reactions or efficacy issues that may arise during its use in a broader population.


Conclusion


Manufacturing hydroxychloroquine sulfate (CAS 747-36-4) is a complex and meticulous process that is vital for ensuring the availability of this important medication. With its applications ranging from treating malaria to managing chronic autoimmune diseases, the role of manufacturers in delivering high-quality, safe products cannot be overstated. The commitment to adhere to rigorous regulatory standards, coupled with a focus on quality control, enables manufacturers to support public health needs effectively. As the landscape of healthcare continues to evolve, the importance of reliable manufacturing processes for essential medications like hydroxychloroquine will remain critical for addressing global health challenges.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
en_USEnglish
afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu en_USEnglish